ストックスクリーナーアプリを入手
1.58
2.47%
-0.04
アフターアワーズ：
1.59
0.01
+0.63%
前日終値:
$1.62
開ける：
$1.62
24時間の取引高:
71,013
Relative Volume:
0.33
時価総額：
$41.56M
収益：
$9.06M
当期純損益:
$-50.39M
株価収益率:
-0.8229
EPS:
-1.92
ネットキャッシュフロー:
$5.89M
1週間 パフォーマンス:
+2.60%
1か月 パフォーマンス:
+1.94%
6か月 パフォーマンス:
+39.82%
1年 パフォーマンス:
-3.66%
1日の値動き範囲:
$1.56
$1.63
1週間の範囲:
$1.54
$1.64
52週間の値動き範囲:
$0.8502
$2.093
Lava Therapeutics Nv Stock (LVTX) Company Profile
LVTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.58 | 42.61M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-12 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-19 | 開始されました | JP Morgan | Overweight |
| 2021-04-19 | 開始されました | Jefferies | Buy |
| 2021-04-19 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Lava Therapeutics Nv (LVTX) 最新ニュース
Is LAVA Therapeutics N.V. forming a reversal patternLayoff News & Expert Approved Momentum Trade Ideas - newser.com
Is LAVA Therapeutics N.V. (4PKB) stock overpriced at current multiplesJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Why LAVA Therapeutics N.V. stock remains resilientTrade Signal Summary & High Win Rate Trade Tips - newser.com
Published on: 2025-10-05 06:23:52 - newser.com
Analyzing recovery setups for LAVA Therapeutics N.V. investorsJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
Measuring LAVA Therapeutics N.V.’s beta against major indicesQuarterly Trade Report & High Conviction Investment Ideas - newser.com
Will LAVA Therapeutics N.V. outperform the marketJuly 2025 Setups & Entry Point Confirmation Signals - newser.com
What candlestick patterns are forming on LAVA Therapeutics N.V.Weekly Trend Recap & Daily Oversold Bounce Ideas - newser.com
How LAVA Therapeutics N.V. stock performs in rate cut cyclesJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Shay Capital LLC Acquires Significant Stake in LAVA Therapeutics NV - GuruFocus
LAVA Therapeutics Extends Tender Offer Deadline - TipRanks
XOMA Royalty extends tender offer deadline for LAVA Therapeutics By Investing.com - Investing.com Australia
XOMA Royalty extends tender offer deadline for LAVA Therapeutics - Investing.com India
XOMA Royalty Corporation Extends Tender Offer for LAVA Therapeutics Shares Until October 17, 2025 - Quiver Quantitative
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - GlobeNewswire
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - Benzinga
75% CVR: XOMA Royalty Extends Tender Offer for LAVA, Extended to Oct. 17 - Stock Titan
What drives LAVA Therapeutics NV stock priceBollinger Bands Signals & High-Risk, High-Reward? We Find the Winners - earlytimes.in
LAVA Therapeutics Postpones EGM for XOMA Deal - MSN
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - GlobeNewswire
LAVA Therapeutics Cancels Extraordinary General Meeting to Finalize XOMA Royalty Acquisition Details - Quiver Quantitative
Biotech Deal Update: LAVA Therapeutics Postpones XOMA Acquisition Vote to Address Cash Position - Stock Titan
Published on: 2025-09-26 19:58:52 - newser.com
Lava Therapeutics Nv (LVTX) 財務データ
収益
当期純利益
現金流量
EPS
2.05%
4.71%
大文字化:
|
ボリューム (24 時間):